![]()
BRS-X-ECS-1-1 - NAPE → NAE Biosynthesis Capacity
1. Mission & Overview
Mission
Enable NAPE-to-NAE biosynthesis so endocannabinoidome signalling lipids remain available for stress and motivation regulation.
Intervention Dominance: Diet-Dominant — No principal intervention route established
The inherited intervention qualification is not confirmed by a mission-specific dietary/practice effect in this assessment.
Overview
N-acylethanolamines are signalling lipids made from membrane phospholipid precursors. This mechanism covers the formation step that supplies these molecules, rather than the later receptor responses or their degradation. Brain and enzyme experiments identify the precursor and catalytic machinery. That makes the synthesis pathway biologically meaningful, while leaving open whether particular foods increase neural production. A tested phosphatidylethanolamine meal did not improve satiety; that outcome does not negate its intracellular precursor role. Cadas et al. (1997) [3]; Magotti et al. (2015) [4]; Lithander et al. (2008) [5]
- Biological Relevance: N-arachidonoyl phosphatidylethanolamine and its biosynthetic pathway were identified in brain preparations. Cadas et al. (1997) [3]
2. Primary Biological Effects
- N-arachidonoyl phosphatidylethanolamine and its biosynthetic pathway were identified in brain preparations. Cadas et al. (1997) [3]
- The membrane substrate enters a binuclear zinc active centre; bile acids influence enzyme organisation and activity. Magotti et al. (2015) [4]
- PE-containing meals did not improve the tested satiety or energy-intake endpoints. Lithander et al. (2008) [5]
3. Levers
- Zinc
- N-acyl phosphatidylethanolamines (NAPEs)
- Phosphatidylethanolamine
No mapping established.
No evidence-qualified System Optimisation Practice is currently established.
No evidence-qualified Lifestyle Lever is currently established.
4. Mechanistic Basis
Summary
N-arachidonoyl phosphatidylethanolamine and its biosynthetic pathway were identified in brain preparations. Cadas et al. (1997) [3]
Mechanism boundary: Whether orally supplied PE/NAPE reaches the relevant neural precursor pool and changes its production; choline participation in other phospholipids does not resolve this link.
4.1 Scientific Findings (3)
Scientific Findings and their source assessments are available in Evidence & Audit.
5. BRS Pathways and Connections
5.1 BRS Pathways
- None listed
5.2 Cross-BRS Mechanism Relationships
Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.
- BRS-X(ECS-FM1) — Endocannabinoidome Signalling Capacity & Neuromodulatory Regulation — Parent integration combines these child processes without establishing a new nutrient or outcome claim.
- BRS-X(ECS-PM2) — Omega-3-Derived Endocannabinoidome Signalling — Supplies the omega-3 acyl branch; shared precursor chemistry does not transfer every nutrient admission.
- BRS-X(ECS-PM3) — FAAH-Mediated Endocannabinoid Preservation — Controls NAE degradation after formation; laboratory inhibition is separate from dietary precursor supply.
- BRS1-FM3-PM7 — Neuronal Membrane DHA Incorporation — DHA is shared lipid context, but membrane incorporation and ethanolamide formation are separately measured processes.
- BRS1(FM1) — Monoaminergic Function — Candidate contextual connection retained for review; an exposure-specific resource or signalling relationship is not yet characterised.
- BRS6(FM2) — HPA Axis Rhythm & Cortisol Regulation — Stress-axis output is an interfacing endpoint; the regional endocannabinoid route is qualified separately from general cortisol regulation.
5.3 Local BRS Mechanism Relationships
Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.
- BRS-X(ECS-PM2) — Omega-3-Derived Endocannabinoidome Signalling — Supplies the omega-3 acyl branch; shared precursor chemistry does not transfer every nutrient admission.
- BRS-X(ECS-PM3) — FAAH-Mediated Endocannabinoid Preservation — Controls NAE degradation after formation; laboratory inhibition is separate from dietary precursor supply.
Phenome assessment boundary: Existing ratings and their original source records are retained pending outcome reassessment. The new mechanism and lever Findings do not validate or raise those ratings.
7. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.
Each Phenome relationship has two independent ratings. They are not combined or averaged.
Biology → Phenome Relationship Strength
How direct and important is this biological mechanism expected to be to the Phenome within the BRAIN model?
Evidence Confidence
How strongly does the adjudicated evidence support this particular biology → Phenome relationship?
- Biology → Phenome Relationship Strength: Low–Medium
- Evidence Confidence: Low–Medium
- Rationale: NAPE → NAE biosynthesis may support AEA, PEA, and OEA signalling context relevant to motivation and drive through diet-actionable endocannabinoidome pathways rather than CB1 receptor pharmacology.
- Biology → Phenome Relationship Strength: Low
- Evidence Confidence: Low
- Rationale: Dietary NAPE and NAE precursor biology may modulate endocannabinoidome context relevant to affective regulation; direct ADHD outcome claims remain cautious.
- Biology → Phenome Relationship Strength: Low–Medium
- Evidence Confidence: Low–Medium
- Rationale: PEA and related NAEs may intersect with stress-buffering endocannabinoidome signalling; dietary phospholipid support remains the primary intervention frame.
8. References
- [1] Garani et al. (2021) — Endocannabinoid System in Psychotic and Mood Disorders, a Review of Human Studies
- [2] Davies et al. (2018) — Oatmeal Effect on N-acyl-phosphatidylethanolamines
- [3] Cadas et al. (1997) — Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain
- [4] Magotti et al. (2015) — Structure of human NAPE-PLD: regulation of fatty-acid ethanolamide biosynthesis by bile acids
- [5] Lithander et al. (2008) — No effect of an oleoylethanolamide-related phospholipid on satiety and energy intake: a randomised controlled trial of phosphatidylethanolamine
No validated structured conversion route is currently projected for this PM. This does not remove or reclassify its existing dietary inputs.
Mapping state: admitted-food-targets-resolved.